⌘K

Login Start Free

Home/Filings/4/0001247741-03-000007

4//SEC Filing

LIGAND PHARMACEUTICALS INC 4

Accession 0001247741-03-000007

$LGNDCIK 0000886163operating

View on SEC.gov Company Profile

Filed

Dec 1, 7:00 PM ET

Accepted

Dec 2, 1:17 PM ET

Size

13.0 KB

Accession

0001247741-03-000007

Insider Transaction Report

Form 4

Period: 2003-12-01

LIGAND PHARMACEUTICALS INCLGND

JOHNSON IRVING S

Director

Transactions

Exercise/Conversion
Common Stock
2003-12-01$9.21/sh+2,494$22,971→ 25,423 total
Sale
Common Stock
2003-12-01$13.88/sh−2,494$34,617→ 22,929 total
Exercise/Conversion
Common Stock
2003-12-01$9.80/sh+5,625$55,125→ 28,554 total
Sale
Common Stock
2003-12-01$13.88/sh−5,625$78,076→ 22,929 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2003-12-01−2,494→ 0 total
Exercise: $9.21From: 1995-05-25Exp: 2004-05-24→ Common Stock (2,494 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2003-12-01−5,625→ 0 total
Exercise: $9.80From: 1995-05-25Exp: 2004-05-25→ Common Stock (5,625 underlying)

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

LIGAND PHARMACEUTICALS INC

CIK 0000886163

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000886163

Filing Metadata

Form type: 4
Filed: Dec 1, 7:00 PM ET
Accepted: Dec 2, 1:17 PM ET
Size: 13.0 KB

View on SEC.gov